Lanmodulin Protein Sequestration of Rare Earth Elements

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

There is a lack of naturally efficient rare-earth element (REE) and radiometal (RM) binding macromolecules, leading to the industry's neglect of proteins in REE and RM life cycles, with a need for sustainable bio-sourced or bio-inspired chelators for selective sequestration.

Innovation Solution

The use of lanmodulin protein (LanM) to sequester and purify rare earth elements and radiometals by binding them in an aqueous solution with a pH of 2.5 to 6.5, followed by pH adjustment to desorb the elements, allowing for repeated cycles of recovery and separation.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If small manmade chelators are used for REE and RM sequestration, then selectivity and binding efficiency can be achieved, but sustainability and environmental friendliness are compromised

Engineering Contradiction:
ImproveselectivityVSAvoidsustainability
Core Design Contradiction:
ReliabilityVSObject-generated harmful factors

Solution Approach 1:

The patent replaces synthetic chemical chelators with a biological system (lanmodulin protein) that naturally binds rare earth elements. This substitution transitions from manmade chemical systems to bio-based systems, achieving both high selectivity through the protein's natural binding sites and sustainability through biodegradability and renewable production from methylotrophic bacteria

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

Solution Approach 2:

The lanmodulin protein naturally performs the sequestration function without requiring additional synthetic additives or complex processing. The protein autonomously binds REEs and RMs through its evolved binding sites, and can be produced sustainably by bacteria that naturally metabolize methanol, creating a self-sufficient system

Inventive Principle:
Principle #25Self-service

2Object-generated harmful factors

If proteins are used for REE and RM binding, then sustainability is improved, but binding efficiency and selectivity are insufficient

Engineering Contradiction:
ImprovesustainabilityVSAvoidbinding efficiency
Core Design Contradiction:
Object-generated harmful factorsVSReliability

Solution Approach 1:

The patent optimizes the protein's binding parameters by engineering lanmodulin with specific amino acid sequences and structures that enhance affinity for REEs and RMs. The protein's binding sites are designed with specific coordination geometries and chemical environments that match the ionic radii and coordination preferences of target elements, achieving binding efficiencies comparable to synthetic chelators

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The patent creates a composite system combining the lanmodulin protein with bacterial production systems and purification protocols. The protein itself is a composite of amino acid sequences engineered for optimal binding, combining natural biocompatibility with enhanced binding properties through directed evolution and rational design

Inventive Principle:
Principle #40Composite materials

3Reliability

If lanmodulin protein is used for sequestration, then selectivity and sustainability are improved, but process complexity increases due to pH control requirements

Engineering Contradiction:
ImproveselectivityVSAvoidprocess complexity
Core Design Contradiction:
ReliabilityVSDevice complexity

Solution Approach 1:

The patent utilizes the dynamic pH-dependent binding behavior of lanmodulin to control sequestration and release cycles. The protein naturally binds REEs and RMs at neutral pH but releases them at acidic pH, creating a dynamic system that responds to environmental conditions. This dynamic behavior simplifies the process by using pH as a simple switch rather than requiring complex operational controls

Inventive Principle:
Principle #15Dynamics

Solution Approach 2:

The patent exploits changes in pH as a simple parameter to control the binding and release cycles. By adjusting pH from neutral (for binding) to acidic (for release), the system achieves selective sequestration and recovery without complex equipment or procedures. This parameter-based control transforms a potentially complex biological process into a simple, scalable operation

Inventive Principle:
Principle #35Parameter changes

4Productivity

If repeated cycles of binding and release are performed, then productivity is improved through reuse, but protein stability is challenged by repeated pH adjustments

Engineering Contradiction:
ImprovereusabilityVSAvoidprotein stability
Core Design Contradiction:
ProductivityVSStability of the object's composition

Solution Approach 1:

The patent designs lanmodulin with enhanced structural stability and resistance to denaturation from pH changes. The protein is engineered with stable folding patterns, disulfide bonds, and amino acid sequences that protect against aggregation and degradation during repeated acid-base cycles. This beforehand reinforcement allows the protein to withstand numerous binding-release cycles without losing functionality

Inventive Principle:
Principle #11Beforehand cushioning (Prior cushioning)

Solution Approach 2:

The patent establishes a continuous cycle of binding and release operations using the same lanmodulin protein repeatedly. The protein maintains its structural integrity and binding capability through multiple pH adjustment cycles, enabling continuous productivity without requiring frequent protein replacement. This continuity is achieved through optimized pH transition protocols and protein stabilization strategies

Inventive Principle:
Principle #20Continuity of useful action

Data Source

PatentUS20210268132A1Methods of sequestering target elements
Publication Date: 2021.09.02 LAWRENCE LIVERMORE NAT SECURITY LLC
  • US20210268132A1 patent drawing
  • US20210268132A1 patent drawing
  • US20210268132A1 patent drawing

AI summary

Provided herein are methods of sequestering target elements (e.g., rare earth elements and/or radiometals) from a sample, methods of purifying target elements from samples, pharmaceutical compositions comprising target elements, and methods of treating a subject with said pharmaceutical compositions.